Home / Morning Report / Morning Report – 17th March 2025

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 17 March 2025

Yesterday’s UK 100 Leaders Price (p) % Chg
Melrose Industries PLC 528.0 6.4%
Games Workshop Group PLC 14,900.0 3.5%
Rolls-Royce Holdings PLC 796.4 3.2%
Scottish Mortgage Investment Trust PLC 967.6 3.0%
Glencore PLC 320.8 2.6%
Yesterday’s UK 100 Laggards Price (p) % Chg
Sainsbury (J) PLC 235.0 -7.8%
Marks And Spencer Group PLC 334.4 -5.2%
Barratt Redrow PLC 420.1 -2.4%
3I Group PLC 3,687.0 -2.1%
Spirax Group PLC 6,965.0 -2.0%
Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 8,632 1.1% 11.7%
DOW JONES INDUS. AVG 41,488 1.7% 7.2%
DAX INDEX 22,987 1.9% 28.2%
NIKKEI 225 37,053 0.7% -4.3%
S&P/ASX 200 INDEX 7,790 0.5% 1.6%
Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 67.18 0.95%
Brent Crude (ICE) USD/bbl. 70.58 1.00%
Gold Spot USD/t oz. 2,984 -0.2%
Copper (Comex) USd/lb. 490 -0.6%
The UK 100 called to open +8 points at 8,640

4 Hours; 10 Months

Click graph to enlarge

Markets Overview:

The UK 100 called to open +8 points at 8,640. The UK 100 looks set to open higher again, as a strong end to an otherwise testing week for global markets on Friday is forecast to continue this morning.

Stocks rallied Friday, clawing back some of the steep losses seen over the week, as investors got a reprieve from tariff-related headlines.  The Dow Jones rose 674.62 points, or 1.65%, to close at 41,488.19. The S&P climbed 2.13% to end at 5,638.94, and the Composite advanced 2.61% to settle at 17,754.09. It was the best day in 2025 for both the S&P 500 and the Nasdaq. Big tech shares that were rattled earlier this week saw a sharp recovery on Friday. Nvidia shares popped more than 5%. Tesla jumped nearly 4%, and Meta Platforms gained close to 3%. Amazon and Apple also rose.

Asian stock markets are trading mostly higher on Monday, following the broadly positive cues from Wall Street on Friday, and as markets react positively to China unveiling a special action plan over the weekend to revive consumption and to boost the stock and real estate market.  The Australian stock market is trading notably higher on Monday, extending the gains in the previous session, following the broadly positive cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is moving well above the 7,800.00 level, with gains across most sectors led by iron ore miners and technology stocks. Gold stocks are the only weak spot.  The Japanese stock market is trading sharply higher on Monday, extending the gains in the previous session, following the broadly positive cues from Wall Street on Friday, with the Nikkei 225 moving above the 37,500 level, with gains across most sectors led by index heavyweights, exporters and technology stocks.  The benchmark Nikkei 225 Index closed the morning session at 37,475.24, up 422.14 points or 1.14 percent, after touching a high of 37,561.21 earlier. Japanese shares ended significantly higher on Friday.

 

Company News & Broker Comments:

Company News:

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The EsoBiotec Engineered NanoBody Lentiviral (ENaBL) platform empowers the immune system to attack cancers and could offer many more patients access to transformative cell therapy treatments delivered in just minutes rather than the current process which takes weeks.  AstraZeneca will acquire all outstanding equity of EsoBiotecfor a total consideration of up to $1bn, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, and up to $575m in contingent consideration based on development and regulatory milestones.  The transaction is expected to close in the second quarter of 2025, subject to customary closing conditions and regulatory clearances. The transaction does not impact AstraZenecas financial guidance for 2025.

Reporting Today:

UK

 

Marshalls (MSLH)

 

US

 

None

 

Reporting Tomorrow:

UK

 

Computacenter (CCC)

Genel Energy (GENL)

Close Brothers Group (CBG)

Trustpilot Group (TRST)

 

US

 

XPeng (XPEV) PMO

In Focus Today:

Chinese Industrial Production

Chinese Retail Sales

German Buba Monthly Report

NY Empire State Manufacturing Index

US Retail Sales

 

This Week’s Ex-Dividends:

UK 100 companies going ex-dividend on 20th March 2025:

 

Hikma Pharmaceuticals

Pearson

Beazley

UK 250 companies going ex-dividend on 20th March 2025:

 

Goodwin

Chemring Group

BlackRock World Mining Trust

Patria Private Equity Trust

HgCapital Trust

Ruffer Investment Company

Law Debenture Corporation

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.